Bimagrumab (BYM338) — Muscle Growth + Fat Loss… So Why Is Nobody Making It?

[lisanovskyi]

Has anyone here heard any recent news about Bimagrumab (BYM338)?

I’m really curious why this compound is still so difficult to find and why nobody seems to be producing an accessible version of it.

What makes Bimagrumab especially interesting is its mechanism. It’s a fully human monoclonal antibody targeting activin type II receptors (ActRIIA/ActRIIB), blocking signaling from myostatin, activins and other ligands involved in limiting skeletal muscle growth.

And the interesting part is that this isn’t just theoretical. Human clinical trials have demonstrated increases in lean mass and skeletal muscle volume, while some studies have also shown substantial reductions in body fat.

From a bodybuilding/body-composition perspective, that’s obviously extremely interesting: potentially more muscle tissue, greater muscle size/hypertrophy, preservation or increase of lean mass while losing fat, and an overall fuller/more muscular appearance as body composition improves.

There are compounds such as YK-11 that often come up when people discuss myostatin and muscle growth, but they’re really not comparable. Bimagrumab is a targeted monoclonal antibody that has undergone human clinical trials, while YK-11 is an experimental synthetic steroidal SARM-like compound with extremely limited human safety and efficacy data.

So what I don’t understand is:
• Why has Bimagrumab never become widely available?
• Has anyone heard anything about BYM338 being produced or becoming more accessible in the future?
• Why hasn’t the research/underground market shown the same interest in it as peptides, GH-related compounds, SARMs, etc.?
• Is manufacturing a monoclonal antibody simply too complicated and expensive?
• Are there other ActRII/myostatin-pathway drugs currently being developed that could offer similar effects?

Considering the potential combination of muscle growth, increased lean mass and significant fat reduction, I’m surprised there isn’t much more discussion about BYM338.

Would love to hear from anyone who has actually followed the Bimagrumab research or knows more about monoclonal antibody development.

 

[The Mentor]

Everyone’s hyping it up right now, but for some reason... nobody stops to think that the drug is still in trials and only available to study participants. It’s extremely complex to manufacture and costs an absolute fortune. Peptides and SARMs are just basic chemical synthesis that any underground lab can cook up.

On top of that, nobody gives a sh*t about the immune response from using some sketchy underground version, let alone the side effects and risks - everyone’s only focused on the gains. How does inhibiting activin/myostatin even impact collagen synthesis and tendon remodeling? There are way too many unanswered questions.

What bugs me is that guys don't have a healthy, scientific curiosity about this... it's just that brain-rot mindset: "I DEFINITELY NEED THIS SO THE GIRL NEXT DOOR SEES MY NEW BICEPS." I was actually chatting with Dr. Dean St. Mart about this and to quote him:

I would hold it in a similar position to Trevogrumab and Garetosmab which we discussed on the Anabolic Roundtable podcast

The cost to utilise them is very significant

They wouldn't necessarily have the same concerns of gene based therapies but they can have unwanted interactions in certain cases

The community is completely clueless about basic pharmacology that any enhanced guy should know. How are they supposed to handle something like Bimagrumab? We’re in a rough spot, guys. Wake up, please.

 

[lisanovskyi]

Everyone’s hyping it up right now, but for some reason... nobody stops to think that the drug is still in trials and only available to study participants. It’s extremely complex to manufacture and costs an absolute fortune. Peptides and SARMs are just basic chemical synthesis that any underground lab can cook up.

On top of that, nobody gives a sh*t about the immune response from using some sketchy underground version, let alone the side effects and risks - everyone’s only focused on the gains. How does inhibiting activin/myostatin even impact collagen synthesis and tendon remodeling? There are way too many unanswered questions.

What bugs me is that guys don't have a healthy, scientific curiosity about this... it's just that brain-rot mindset: "I DEFINITELY NEED THIS SO THE GIRL NEXT DOOR SEES MY NEW BICEPS." I was actually chatting with Dr. Dean St. Mart about this and to quote him:

The community is completely clueless about basic pharmacology that any enhanced guy should know. How are they supposed to handle something like Bimagrumab? We’re in a rough spot, guys. Wake up, please.

I understand the risks. I wasn’t asking for a lecture on whether people should use Bimagrumab or whether underground products can be dangerous.

The same arguments can be made about steroids, peptides, SARMs, or practically any performance-enhancing drug. Some people use them irresponsibly, while others do extensive research, monitor bloodwork, understand pharmacology, and accept the risks involved.

My question was purely about availability and capability:

Is Bimagrumab/BYM338 something you could realistically manufacture or source in the foreseeable future — even initially in a small batch for independent testing — or is it simply outside your capabilities?

There are already sources claiming to offer it in the US and CIS countries, and there are people willing to pay serious money for a properly manufactured and independently tested product.

I’m not asking whether you personally recommend using it. I’m asking whether producing/sourcing it is technically and commercially realistic for you.

A simple “yes, potentially,” “not anytime soon,” or “no, we can’t” would answer my question.

If the answer is no, that’s completely fine — I’ll simply look elsewhere.

 

[The Mentor]

I understand the risks. I wasn’t asking for a lecture on whether people should use Bimagrumab or whether underground products can be dangerous.

The same arguments can be made about steroids, peptides, SARMs, or practically any performance-enhancing drug. Some people use them irresponsibly, while others do extensive research, monitor bloodwork, understand pharmacology, and accept the risks involved.

My question was purely about availability and capability:

Is Bimagrumab/BYM338 something you could realistically manufacture or source in the foreseeable future — even initially in a small batch for independent testing — or is it simply outside your capabilities?

There are already sources claiming to offer it in the US and CIS countries, and there are people willing to pay serious money for a properly manufactured and independently tested product.

I’m not asking whether you personally recommend using it. I’m asking whether producing/sourcing it is technically and commercially realistic for you.

A simple “yes, potentially,” “not anytime soon,” or “no, we can’t” would answer my question.

If the answer is no, that’s completely fine — I’ll simply look elsewhere.

Bro, you started a discussion thread on a forum that's meant for actual discussions, not for getting rigid yes/no customer support answers. For that, you've got the "Your Wishes" section.

The whole mindset of some guys -honestly, most of them... is just chasing hype and gains while totally blowing off the actual scale of the risks. Which is precisely what I was talking about regarding the current state of the community: people are ready to pin literally anything into their ass just to add an extra inch to their biceps. If anyone honestly thinks you can just whip up or source monoclonal antibodies like it's no big deal, then... no words.

I didn't drop a detailed breakdown to preach or play hall monitor, but rather to highlight the massive chasm between standard peptide synthesis in some labs and actual biotech protein manufacturing. But hey, if you'd rather blindly trust sketchy vendors and completely gloss over the biological consequences - which you conveniently left out of your post, of course... then... u can "simply look elsewhere", my bro )

And that's just my personal take. Aren't we here to share perspectives and actually learn a thing or two? Or have we already figured it all out? )